Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
reduced circulation), infections, and ulcers
Eat small, balanced meals to manage lingering nausea
In April 2026, the FDA approved a new glucagon-like peptide-1 receptor agonist (GLP-1 RA)
To continue reading either: Access your account Log in to your account to access your content on Nursing Times
Lactated Ringers Member Pricing $115 | $135 Balanced electrolyte hydration supporting energy, blood pressure, and cellular function
Key findings from the Phase 2 trial included: Dose-dependent weight loss , with greater reductions observed at higher doses Significant improvements in waist circumference , blood pressure , and lipid profiles Reductions in fasting glucose and insulin resistance markers, though the clinical significance of these findings in people with type 2 diabetes requires further investigation Weight loss appeared to continue throughout the 48-week period without a clear plateau at the highest doses Whilst these results are encouraging, it is important to contextualise them appropriately
US$ 28.11
US$ 27.13
US$ 24.51
